Boundless Bio (BOLD) Stock Price, Quote, News & History | Benzinga

Boundless Bio Inc (BOLD) Stock Price, Quote, News & History

BOLDNASDAQ

Trade with Public

Trade with Public

$2.80

0.0953.51%

At close: Aug 5, 5:00 PM EST

$2.82

0.01550.55%

After Hours: 6:58 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Stock Report

Key Statistics

Open

$2.72

Close

$2.80

Volume / Avg.

527.37K / 1.24M

Day Range

$2.72 - $2.92

52 Wk Range

0.96 - 2.92

Market Cap

$63.28M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

81

Short Interest

1.79%

Days to Cover

1.01

Recent Boundless Bio, Inc. News

Crude Oil Down Over 1%; US Manufacturing PMI Surges In June

US stocks lower, Nasdaq falls 500 points. Dow down 0.04%, Nasdaq 1.91%, S&P 500 1.27%. Consumer staples up 1.4%, tech down 2.3%. S&P PMI rises.

Avi Kapoor

Dow Falls Over 300 Points; Korn Ferry Earnings Top Views

US stocks down as Dow falls 300 points, while S&P 500 and NASDAQ also decrease. Consumer staples rise, tech stocks fall. Korn Ferry beats earnings.

Avi Kapoor

The Daily Biotech Pulse: Xeris Jumps On Positive Data, Mixed Results For Merck's Keytruda-Chemo Combo In Lung Cancer, Intra-Cellular Announces Offering

Shanthi Rexaline

Stocks That Hit 52-Week Highs On Friday

Lisa Levin

The Daily Biotech Pulse: Flexion Receives FDA Nod For Zilretta Label Expansion, Astellas Goes Shopping

Shanthi Rexaline

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-47.10M

Investing Cash Flow (TTM)

49.33M

Financing Cash Flow (TTM)

141.00K

Free Cash Flow (TTM)

-47.60M

Capital Expenditure (TTM)

-495.00K

Net Change in Cash (TTM)

2.37M

Analyst Rating and Forecast

3.1

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$18.37M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

0.73

Earnings Yield % (TTM)

-88.93%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$3.84

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$17.48M

Debt to Equity

0.56

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$2.72

Close

$2.80

Volume / Avg.

527.37K / 1.24M

Day Range

$2.72 - $2.92

52 Wk Range

0.96 - 2.92

Market Cap

$63.28M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

81

Short Interest

1.79%

Days to Cover

1.01

About

Sector

Health Care

Industry

Biotechnology

Boundless Bio Inc is a clinical-stage oncology company. It is focused on developing cancer therapeutics that address the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplifi...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Boundless Bio (BOLD) stock?

A

You can purchase shares of Boundless Bio (NASDAQ:BOLD) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Boundless Bio (BOLD) competitors?

A

There are no as such competitors for Boundless Bio.

Q

What is the forecast, or price target, for Boundless Bio (BOLD) stock?

A

Boundless Bio has a consensus price target of $8.00.

Q

What is the current price for Boundless Bio (BOLD)?

A

The stock price for Boundless Bio (NASDAQ: BOLD) is $2.8155 last updated August 5, 2026 at 6:58 PM EDT.

Q

Does Boundless Bio (BOLD) pay a dividend?

A

There are no upcoming dividends for Boundless Bio.

Q

When is Boundless Bio (NASDAQ:BOLD) reporting earnings?

A

Boundless Bio does not have any upcoming earnings scheduled.

Q

Is Boundless Bio (BOLD) going to split?

A

There is no upcoming split for Boundless Bio.

Q

What sector and industry does Boundless Bio (BOLD) operate in?

A

Boundless Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.